Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
ArchivedFood and Drug Administration
Description
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance COVID-19 health equity research.Areas of interest include:Proposals that focus on advancing racial and ethnic minority participation in COVID-19/COVID-19 variant clinical trials and/or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) or products subject to EUAs/EUA expansion for the treatment, prevention, or diagnosis of COVID-19. Proposals that support the evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability, and geography.Proposals that support COVID-19 research to understand diverse patient perspectives, preferences, and unmet needs
Who can apply
- Independent school districts
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
Shashi Malhotra <br/>Grants Management Specialist <br/>Phone 2404027592
shashi.malhotra@fda.hhs.gov
- PostedSep 27, 2021
- ClosesNov 29, 2021
- Award floor$200,000
- Award ceiling$1,000,000
- Expected awards5
- CFDA93.103
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro